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Lidocaine hydrochloride (HCl) is a common local anaesthetic with a short time of drug action and 
relatively long period of sustained delivery1. Additional active molecules, such as tetracaine and 
adrenaline, are used in topical lidocaine ointment to enhance lidocaine HCl delivery. However, these 
molecules compete with the injected lidocaine HCl2. For example, adrenaline is likely to cause a reduced 
percutaneous delivery of lidocaine HCl3,4. Microneedle assisted delivery of lidocaine HCl involves the 
creation of artificial pores to bypass the SC layer of skin for delivery of lidocaine HCl 5. Unlike topical 
based ointments, injectable lidocaine HCl can produce a burning sensation and is suitable for less 
sustained percutaneous delivery6,7. However, the time delay between skin surface applications of 
eutectic mixtures of local anaesthetics (EMLA) to permeating at a depth of 3000µm is 60 minutes8. In the 
present work, a pre-fabricated set of stainless steel microneedles with a needle interspacing of 1100µm 
was impacted on dissected porcine skin section at a force of ~0.09 N per needle5. A novel lidocaine 
hydrogel was also formulated with approximately half the mass loading of local anaesthetics contained in 
Lidoderm and EMLA formulation5,9,10. A poke and patch method was adopted in directing the polymeric 
hydrogel into the microneedles holes on skin. Mild pseudoplasticity resembling an ointment formulation 
for lidocaine NaCMC:gel hydrogel remained constant when lidocaine HCl loading mass increased. 
Gelatine (gel) to sodium carboxymethylcellulose (NaCMC) mass ratio of 2.3 resulted in highly favourable 
zeta potentials when lidocaine HCl 2.4% w/w was loaded. Microneedle assisted lidocaine delivery of gel 
to NaCMC mass ratio of 2.3 resulted in crossing a minimum therapeutic level at skin depths of ~730µm 
before 70 minutes (Fig. 1). The lidocaine permeation flux was 1.7 times greater for gel to NaCMC mass 
ratio of 2.3 compared with a mass ratio of 1.6 under microneedle assisted delivery (Fig. 2).  
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